Mawer Investment Management’s Concentrix CNXC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-169,766
Closed -$10.7M 104
2024
Q2
$10.7M Buy
169,766
+48,999
+41% +$2.94M 0.05% 91
2024
Q1
$8M Buy
120,767
+68,640
+132% +$5.57M 0.04% 88
2023
Q4
$5.12M Buy
52,127
+3,908
+8% +$340K 0.03% 81
2023
Q3
$3.86M Buy
48,219
+14,245
+42% +$1.12M 0.02% 82
2023
Q2
$2.74M Buy
33,974
+12,024
+55% +$1.12M 0.01% 89
2023
Q1
$2.67M Buy
21,950
+3,334
+18% +$453K 0.01% 87
2022
Q4
$2.48M Buy
18,616
+3,357
+22% +$408K 0.01% 89
2022
Q3
$1.7M Buy
15,259
+4,290
+39% +$549K 0.01% 89
2022
Q2
$1.49M Buy
10,969
+2,571
+31% +$387K 0.01% 84
2022
Q1
$1.4M Buy
8,398
+3,155
+60% +$599K 0.01% 87
2021
Q4
$937K Buy
5,243
+3,431
+189% +$612K ﹤0.01% 99
2021
Q3
$321K Buy
+1,812
New +$300K ﹤0.01% 101

Other funds holding CNXC

Mawer Investment Management's CNXC Position: Q3 2024 in Review

Mawer Investment Management sold out of Concentrix (CNXC) in Q3 2024, closing a stake of 169,766 shares — an estimated $10.7M sold.

Mawer Investment Management first reported a position in CNXC in Q3 2021 and held it in 12 quarters. The position peaked at $10.7M in Q2 2024. 284 funds tracked by Wall St. Rank hold CNXC as of Q3 2024.

  • Mawer Investment Management reported no remaining Concentrix position as of Q3 2024 after selling out during the quarter.
  • Mawer Investment Management sold 169,766 Concentrix shares in Q3 2024, an estimated $10.7M.
  • Mawer Investment Management first reported a position in Concentrix in Q3 2021 and held it in 12 quarters.
  • Mawer Investment Management's Concentrix position peaked at $10.7M in Q2 2024.
  • 284 funds tracked by Wall St. Rank held Concentrix as of Q3 2024.

Based on Mawer Investment Management's 13F filing for Q3 2024, filed 7 Nov 2024.